You have 9 free searches left this month | for more free features.

Condition

Advanced Malignancies (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (1)

Sponsor

BioInvent International AB (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

bi-1808 (1)

pembrolizumab 25 mg/ml solution for injection (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

bi-1808

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Malignancies Trial in Denmark, Hungary, Russian Federation (BI-1808, Pembrolizumab 25 Mg/mL Solution for Injection)

Recruiting

Advanced Malignancies

BI-1808
Pembrolizumab 25 Mg/mL Solution for Injection

Copenhagen, Denmark
+11 more

Sep 9, 2022